Evidence map›Paper›PMID 41221569›Full record

ArticleIndian journal of pharmacology2025

An analysis of awareness and acceptability of the Medicines Side Effect Reporting Form for Consumer and the quality of data entered by consumers - An Indian perspective.

Ratinder Jhaj, Ajay Kumar Shukla, Sameer Uttamrao Khasbage, Deepa Chaudhary, Shah Newaz Ahmed

Abstract read
In one paragraph

Article in Indian journal of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ratinder JhajDepartment of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Ajay Kumar ShuklaDepartment of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Sameer Uttamrao KhasbageDepartment of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Deepa ChaudharyDepartment of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Shah Newaz AhmedDepartment of Pharmacology, MJN Medical College and Hospital, Cooch Behar, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsumers are key stakeholders in drug safety, yet, till recently, their potential has remained untapped in terms of contributing to the drug safety data. The Medicines Side Effect Reporting Form for Consumer (MSERC), launched by the Pharmacovigilance Programme of India, is an important tool for the consumer to report adverse drug reactions (ADRs).

objectiveOur objective was to evaluate the awareness and acceptability of the MSERC among the general population and the quality of data entered by the consumers.

methodsThis was a cross-sectional study carried out at a tertiary healthcare center in Madhya Pradesh (Central India).

resultsThe study included 203 participants, with 115 self-reports and 88 reports of ADRs experienced by a relative. All mandatory fields were filled by 149 (73.4%) participants. More than half of the reporters (113, 55.57%) took <5 min to fill the form and found it easy to fill it (123, 60.59%). Most of the participants expressed a willingness (186, 91.63%) to fill the MSERC. The time taken to complete the form and the difficulty in filling the form were significantly greater in the elderly (age >60 years). Significantly more women were aware about the MSERC (P = 0.026), as compared to men. Participants with graduate, postgraduate, or professional degrees took significantly less time to fill the form (P < 0.001) and found it easier to fill it (P = 0.019).

conclusionAwareness about the form was found in only 6.4% of the responders, highlighting a need to generate more awareness among the consumers about the MSERC form to improve the ADR reporting.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHealth Knowledge, Attitudes, PracticePharmacovigilanceAdolescentAdultAgedCross-Sectional StudiesFemaleHumansIndiaMaleMiddle AgedYoung AdultAdverse drug reactionsconsumer feedbackpharmacovigilancePharmacovigilance Programme of Indiaside effects

Identifiers

PMID41221569
PMCPMC12662611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.